Molecular analysis of sepsis-induced changes in the liver: Microarray study in a porcine model of acute fecal peritonitis with fluid resuscitation

Shock

Volumn 34, Issue 4, 2010, Pages 427-436

  Van Malenstein, Hannah ^a   Wauters, Joost ^b   Mesotten, Dieter ^b   Langouche, Lies ^b   De Vos, Rita ^c   Wilmer, Alexander ^c   Van Pelt, Jos ^a  

^a Faculty of Medicine   (Belgium)

^b LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Acute sepsis; fluid resuscitation; inflammation; intensive care medicine; microarray

Indexed keywords

CXCL2 CHEMOKINE; INTERLEUKIN 6; INTERLEUKIN 8;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; COMPUTER ANALYSIS; FEMALE; FLUID RESUSCITATION; GENE EXPRESSION; GENE IDENTIFICATION; INFLAMMATION; LIVER FUNCTION; MICROARRAY ANALYSIS; NONHUMAN; OXIDATION REDUCTION STATE; PERITONITIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; UPREGULATION;

ANIMALS; CHEMOKINE CCL2; CHEMOKINE CXCL2; FLUID THERAPY; INTERLEUKIN-8; LIVER; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERITONITIS; RESUSCITATION; SEPSIS; SWINE;

EID: 77957709363     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181dc41aa     Document Type: Article

References (39)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303-1310, 2001.
2. Van Amersfoort ES, Van Berkel ThJC, Kuiper J: Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16(3):379-414, 2003.
3. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early Goal-Directed Therapy Collaborative Group: early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368-1377, 2001.
4. Singer M: Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit Care Med 35(Suppl 9):S441YS448, 2007.
5. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF: Neutrophils in development of multiple organ failure in sepsis. Lancet 368(9530):157-169, 2006.
6. Hawker F: Liver dysfunction in critical illness. Anaesth Intensive Care 19: 165-181, 1991.
7. Kortgen A, Paxian M, Werth M, Recknagel P, Rauchfuss F, Lupp A, Krenn CG, Müller D, Claus RA, Reinhart K, et al.: Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock 32(4):358-365. 2009.
8. Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, Meyer K, Freishtat RJ, Monaco M, Odoms K, Sakthivel B, et al.: Genomics of Pediatric SIRS/Septic Shock Investigators: genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 37(5):1558-1566, 2009.
9. Payen D, Lukaszewicz AC, Belikova I, Faivre V, Gelin C, Russwurm S, Launay JM, Sevenet N: Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Med 34(8):1371-1376, 2008.
10. Croner RS, Hohenberger W, Jeschke MG: Hepatic gene expression during endotoxemia. J Surg Res 154:126-134, 2009.
11. Wauters J, Mesotten D, Van Zwam K, Van Pelt J, Thiessen S, Dieudonné AS, Vanderborght S, Van Den Berghe G, Wilmer A: The impact of resuscitated fecal peritonitis on the expression of the hepatic bile salt transporters in a porcine model. Shock. 2010 Mar 30. [Epub ahead of print].
12. Hauser B, Barth E, Bassi G, Simon F, Gröger M, Oter S, Speit G, Ploner F, Möller P, Wachter U, et al.: Hemodynamic, metabolic, and organ function effects of pure oxygen ventilation during established fecal peritonitis-induced septic shock. Crit Care Med. 37(8):2465-2469, 2009.
13. Chvojka J, Sykora R, Krouzecky A, Radej J, Varnerova V, Karvunidis T, Hes O, Novak I, Radermacher P, Matejovic M: Renal haemodynamic, micro-circulatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs. Crit Care 12(6):R164, 2008.
14. Tsai S, Cassady JP, Freking BA, Nonneman DJ, Rohrer GA, Piedrahita JA: Annotation of the Affymetrix1 porcine genome microarray. Anim Gen 37:423-424, 2006.
15. Salomonis N, Hanspers K, Zambon AC, Vranizan K, Lawlor SC, Dahlquist KD, Doniger SW, Stuart J, Conklin BR, Pico AR: GenMAPP 2: new features and resources for pathway analysis. BMC Bioinformatics 8:217, 2007.
16. Available at http://www.geneontology.org/. Accessed May 2009.
17. Available at http://string-db.org/. Accessed November 2009.
18. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, et al.: STRING 8Va global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37(database issue):D412YD416, 2009.
19. Mesotten D, Van Den Berghe G, Liddle C, Coulter S, McDougall F, Baxter RC, Delhanty PJ: Growth hormone modulation of the rat hepatic bile transporter system in endotoxin-induced cholestasis. Endocrinology 144:4008-4017, 2003.
20. Vos TA, Hooiveld GJ, Koning H, Childs S, Meijer DK, Moshage H, Jansen PL, Muller M: Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28:1637-1644, 1998.
21. Andrejko KM, Raj NR, Kim PK, Cereda M, Deutschman CS: IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters. Shock 29(4):490-496. 2008.
22. Messaris E, Kekis P, Memos N, Chatzigianni E, Menenakos E, Leandros E, Konstadoulakis MM: Sepsis: prognostic role of apoptosis regulators in gastrointestinal cells. World J Surg 31:787-794, 2007.
23. Crawford JH, Yang S, Zhou M, Simms HH, Wang P: Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit Care Med 32(2):502-508, 2004.
24. Kozlov AV, Duvigneau JC, Miller I, Nürnberger S, Gesslbauer B, Kungl A, Ohlinger W, Hartl RT, Gille L, Staniek K, et al.: Endotoxin causes functional endoplasmic reticulum failure, possibly mediated by mitochondria. Biochim Biophys Acta 1792(6):521-530, 2009.
25. Kozlov AV, Gille L, Miller I, Piskernik C, Haindl S, Staniek K, Nohl H, Bahrami S, Ohlinger W, Gemeiner M, et al.: Opposite effects of endotoxin on mitochondrial and endoplasmic reticulum functions. Biochem Biophys Res Commun 352(1):91-96, 2007.
26. Yasui H, Hayashi S, Sakurai H: Possible involvement of singlet oxygen species as multiple oxidants in p450 catalytic reactions. Drug Metab Pharmacokinet 20(1):1-13, 2005.
27. Miller I, Gemeiner M, Gesslbauer B, Kungl A, Piskernik C, Haindl S, Nürnberger S, Bahrami S, Redl H, Kozlov AV: Proteome analysis of rat liver mitochondria reveals a possible compensatory response to endotoxic shock. FEBS Lett 580(5):1257-1262, 2006.
28. Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Kitzberger R, Warszawska J, et al.: Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 35(8):1397-1405, 2009.
29. Zamara E, Galastri S, Aleffi S, Petrai I, Aragno M, Mastrocola R, Novo E, Bertolani C, Milani S, Vizzutti F, et al.: Prevention of severe toxic liver injury and oxidative stress in MCP-1Ydeficient mice. J Hepatol 46(2):230-238, 2007.
30. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT: Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11(2):R49, 2007.
31. Ramnath RD, Ng SW, Guglielmotti A, Bhatia M: Role of MCP-1 in endotox-emia and sepsis. Int Immunopharmacol 8(6):810-818, 2008.
32. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL: Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect Immun 65(9):3847-3851, 1997.
33. Villar J, Pérez-Méndez L, Flores C, Maca-Meyer N, Espinosa E, Muriel A, Sangüesa R, Blanco J, Muros M, Kacmarek RM: A CXCL2 polymorphism is associated with better outcomes in patients with severe sepsis. Crit Care Med 35(10):2292-2297, 2007.
34. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653-658, 1987.
35. McKallip RJ, Fisher M, Gunthert U, Szakal AK, Nagarkatti PS, Nagarkatti M: Role of CD44 and its v7 isoform in staphylococcal enterotoxin BYinduced toxic shock: CD44 deficiency on hepatic mononuclear cells leads to reduced activation-induced apoptosis that results in increased liver damage Infect Immun 73(1):50-61, 2005.
36. McDonald B, McAvoy EF, Lam F, Gill V, De la Motte C, Rashmin C, Savani RC, Kubes P: Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J Exp Med 205(4): 915-927, 2008.
37. Larche J, Lancel S, Hassoun SM, Favory R, Decoster B, Marchetti P, Chopin C, Neviere R: Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality. J Am Coll Cardiol 48(2): 377-385, 2006.
38. Crouser ED, Julian MW, Huff JE, Joshi MS, Bauer JA, Gadd ME, Wewers MD, Pfeiffer DR: Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia. Crit Care Med 32(2):478-488, 2004.
39. Song XM, Li JG, Wang YL, Hu ZF, Zhou Q, Du ZH, Jia BH: The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats. Shock 30(4):468-472, 2008.